There is high variability in the response to antiepileptic treatment across people with epilepsy.
Genetic factors significantly contribute to such variability. Recent advances in the genetics …

Sequencing-based studies have identified novel risk genes associated with severe epilepsies
and revealed an excess of rare deleterious variation in less-severe forms of epilepsy. To …

Objective: To evaluate the phenotypic spectrum associated with mutations in TBC1D24.
Methods: We acquired new clinical, EEG, and neuroimaging data of 11 previously unreported …

Objective The processes underlying sudden unexpected death in epilepsy ( SUDEP ) remain
elusive, but centrally mediated cardiovascular or respiratory collapse is suspected. Volume …

Purpose To define the phenotypic and mutational spectrum of epilepsies related to DEPDC5,
NPRL2 and NPRL3 genes encoding the GATOR1 complex, a negative regulator of the …

Objective: To evaluate whether severe carotid stenosis and related hemodynamics impairment
may increase the risk of cognitive deterioration in asymptomatic subjects. Methods: A …

Sudden unexpected death in epilepsy is a major cause of premature death in people with
epilepsy. We aimed to assess whether structural changes potentially attributable to sudden …

Epilepsy syndromes have been recognized for >50 years, as distinct electroclinical
phenotypes with therapeutic and prognostic implications. Nonetheless, no formally accepted …

Developmental and epileptic encephalopathies (DEEs) are a heterogeneous group of disorders
characterized by early-onset, often severe epileptic seizures and EEG abnormalities on …

Recently, de novo mutations in the gene KCNA2, causing either a dominant-negative loss-of-function
or a gain-of-function of the voltage-gated K + channel K v 1.2, were described to …